Lab-on-a-Chip - Global Strategic Business Report 2026: Capitalize on a 9.8% CAGR to Secure Your Share in the US$13.6 Billion Market by 2032

ملخص مفصل

Rapid diagnostics, personalized medicine and portable microfluidics drive adoption, while segment, regional and competitive insights reveal new revenue opportunitiesDublin, Nov.…

Rapid diagnostics, personalized medicine and portable microfluidics drive adoption, while segment, regional and competitive insights reveal new revenue opportunities

Dublin, Nov. 13, 2026 (GLOBE NEWSWIRE) -- "Lab-on-a-Chip - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering.

The global lab-on-a-chip market, valued at US$7 billion in 2025, is projected to reach US$13.6 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.8%. Market growth is being supported by rising demand for rapid diagnostics, advances in personalized medicine and genomics, and the increasing adoption of portable, miniaturized laboratory systems.

The comprehensive market report examines the technologies, applications, end users, competitive developments and regional trends shaping the global lab-on-a-chip industry. It provides independent market forecasts and strategic insights designed to support investment planning, product development, competitive benchmarking and long-term business decisions.

Lab-on-a-chip technology is transforming clinical diagnostics by integrating sample preparation, detection and analysis into compact microfluidic platforms. These systems support rapid, accurate and cost-efficient testing, making them increasingly important in point-of-care diagnostics, emergency medicine and decentralized healthcare environments.

The ability to identify biomarkers, pathogens and genetic mutations at the point of need is accelerating the transition from centralized laboratory testing to more accessible diagnostic models. Adoption is also increasing in remote and resource-constrained settings, where conventional laboratory infrastructure may be unavailable or impractical.

Growth in personalized medicine is increasing demand for lab-on-a-chip systems capable of supporting precise molecular and genetic analysis.

Oncology represents a particularly important opportunity as healthcare providers and pharmaceutical companies expand the use of…

M…

مطلع المقال، مقتطف من Yahoo Finance. لقراءة المقال كاملًا، افتحه على موقع الناشر.